Correction to Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation [The Journal of Experimental Medicine, 209, 6, (2012) 1105-1119]

Claus Werner Franzke, Cristina Cobzaru, Antigoni Triantafyllopoulou, Stefanie Löffek, Keisuke Horiuchi, David W. Threadgill, Thomas Kurz, Nico van Rooijen, Leena Bruckner-Tuderman, Carl P. Blobel

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish
Number of pages1
JournalJournal of Experimental Medicine
Volume209
Issue number13
DOIs
Publication statusPublished - 2012 Dec 17

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Franzke, C. W., Cobzaru, C., Triantafyllopoulou, A., Löffek, S., Horiuchi, K., Threadgill, D. W., Kurz, T., van Rooijen, N., Bruckner-Tuderman, L., & Blobel, C. P. (2012). Correction to Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation [The Journal of Experimental Medicine, 209, 6, (2012) 1105-1119]. Journal of Experimental Medicine, 209(13). https://doi.org/10.1084/jem.2011225820913c